Medscape9d
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
Vancomycin 265/309 (85.8%) 76/265 (25.3%) 198/309 (64.1%) † Clinical cure is resolution of diarrhea following the recommended dose of drug (fidaxomicin: 200 mg twice a day; vancomycin ...
phillyvoice.com7h
FDA approves non-opioid painkiller, first new class in decades
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...